Development of the Caco-2 Model for Assessment of Iron Absorption and Utilisation at Supplemental Levels


 Ferrous sulphate, soluble iron, Caco-2, TEER, ferric maltol, iron supplementation, ferritin formation, iron uptake, iron utilisation.

How to Cite

Bianca I. Mergler, Ewgenia Roth, Sylvaine F.A. Bruggraber, Jonathan J. Powell, & Dora I.A. Pereira. (2012). Development of the Caco-2 Model for Assessment of Iron Absorption and Utilisation at Supplemental Levels . Journal of Pharmacy and Nutrition Sciences, 2(1), 26–33.


Caco-2 cells may be typically used as a first step to investigate the bioavailability of different dietary and fortificant forms of iron (Fe) at low levels (< 10 µM) in tissue culture medium (TCM). Whether this model is suitable with supplemental levels of Fe (ca. 200 µM in TCM) is not clear and neither, therefore, is the choice of reference iron compound under those conditions as a ‘positive control’. Here we show that with 200 ?M iron in TCM (serum-free MEM), Fe(II) sulphate precipitates and while high levels of ascorbic acid can prevent this, it is to the detriment of the Caco-2 cell monolayer and/or it adversely affects the pH of the TCM. Adjusting the pH of TCM to account for this issue again leads to Fe precipitation, which is detectable as both a true precipitate (~ 50%) and a nano-precipitate in suspension (~20%). In contrast, Fe(III) maltol which, clinically, appears less toxic to the intestinal mucosa than Fe(II) sulphate, retains solubility at supplemental levels in cell culture medium, without adversely affecting pH or the Caco-2 cell monolayer. Moreover, the iron is also well utilized by the cells as assessed through ferritin formation. Thus Caco-2 cells may also provide a model for screening iron uptake and utilisation at supplemental levels through the cellular generation of ferritin although care must be taken in ensuring (i) appropriate TCM conditions (e.g. pH and chemical speciation of the iron) (ii) monolayer integrity (i.e. the assay response is not an artefact of toxicity) and (iii) that an appropriate reference material is used (e.g. Fe:maltol at 1:5 ratio).


Glover J, Jacobs A. Observations on iron in the jejunal lumen after a standard meal. Gut 1971; 12: 369-71.

Dressman JB. Comparison of canine and human gastrointestinal physiology. Pharmaceut Res 1986; 3: 123-31.

Radcliffe DV. Stomach. In: Company TL, editor. Compton's Encyclopeadia Online v301998.

Bevan J. Handbook of Anatomy and Physiology. New York: Simon & Schuster 1978.

Kalgaonkar S, Lonnerdal B. Effects of dietary factors on iron uptake from ferritin by Caco-2 cells. J Nutr Biochem 2008; 19: 33-9.

Glahn RP, Rassier M, Goldman MI, Lee OA, Cha J. A comparison of iron availability from commercial iron preparations using an in vitro digestion/Caco-2 cell culture model. J Nutr Biochem 2000; 11: 62-8.

Dorey C, Cooper C, Dickson DP, Gibson JF, Simpson RJ, Peters TJ. Iron speciation at physiological pH in media containing ascorbate and oxygen. Br J Nutr 1993; 70: 157-69.

Zhu L, Glahn RP, Yeung CK, Miller DD. Iron uptake by Caco-2 cells from NaFeEDTA and FeSO4: Effects of ascorbic acid, pH, and a Fe(II) chelating agent. J Agric Food Chem 2006; 54: 7924-8.

Jin F, Frohman C, Thannhauser TW, Welch RM, Glahn RP. Effects of ascorbic acid, phytic acid and tannic acid on iron bioavailability from reconstituted ferritin measured by an in vitro digestion-Caco-2 cell model. Br J Nutr 2008: 1-10.

Tsuruta H, Yagishita T, Shimizu M, Tamura H. Megadose vitamin C suppresses sulfoconjugation in human colon carcinoma cell line Caco-2. Toxicol In Vitro 2011; 25: 500-4.

Scheers NM, Sandberg AS. Ascorbic acid uptake affects ferritin, Dcytb and Nramp2 expression in Caco-2 cells. Eur J Nutr 2008; 47: 401-8.

Scheers NM, Sandberg AS. Iron regulates the uptake of ascorbic acid and the expression of sodium-dependent vitamin C transporter 1 (SVCT1) in human intestinal Caco-2 cells. Br J Nutr 2011: 1-7.

Natoli M, Felsani A, Ferruzza S, Sambuy Y, Canali R, Scarino ML. Mechanisms of defence from Fe(II) toxicity in human intestinal Caco-2 cells. Toxicol In Vitro 2009; 23: 1510-5.

Ferruzza S, Scacchi M, Scarino ML, Sambuy Y. Iron and copper alter tight junction permeability in human intestinal Caco-2 cells by distinct mechanisms. Toxicol In Vitro 2002; 16: 399-404.

Moyes SM, Morris JF, Carr KE. Culture conditions and treatments affect Caco-2 characteristics and particle uptake. Int J Pharm 2009.

Beiseigel JM, Hunt JR, Glahn RP, Welch RM, Menkir A, Maziya-Dixon BB. Iron bioavailability from maize and beans: a comparison of human measurements with Caco-2 cell and algorithm predictions. Am J Clin Nutr 2007; 86: 388-96.

Bengtsson A, Scheers N, Andlid T, Alminger ML, Sandberg AS, Svanberg U. Impaired uptake of beta-carotene by Caco-2 human intestinal cells in the presence of iron. Int J Food Sci Nutr 2009; 60: 125-35.

Glahn RP, Wortley GM, South PK, Miller DD. Inhibition of iron uptake by phytic acid, tannic acid, and ZnCl2: studies using an in vitro digestion/Caco-2 cell model. J Agric Food Chem 2002; 50: 390-5.

Thompson B, Sharp P, Elliott R, Al-Mutairi S, Fairweather-Tait SJ. Development of a modified Caco-2 cell model system for studying iron availability in eggs. J Agric Food Chem 2010; 58: 3833-9.

Glahn RP, Wien EM, Van Campen DR, Miller DD. Caco-2 cell iron uptake from meat and casein digests parallels in vivo studies: use of a novel in vitro method for rapid estimation of iron bioavailability. J Nutr 1996; 126: 332-9.

He WL, Feng Y, Li XL, Yang XE. Comparison of iron uptake from reduced iron powder and FeSO4 using the Caco-2 cell model: effects of ascorbic acid, phytic acid, and pH. J Agric Food Chem 2008; 56: 2637-42.

Arredondo M, Kloosterman J, Nunez S, Segovia F, Candia V, Flores S et al. Heme iron uptake by Caco-2 cells is a saturable, temperature sensitive and modulated by extracellular pH and potassium. Biol Trace Elem Res 2008; 125: 109-19.

Kalgaonkar S, Lonnerdal B. Receptor-mediated uptake of ferritin-bound iron by human intestinal Caco-2 cells. J Nutr Biochem 2009; 20: 304-11.

Kilari S, Pullakhandam R, Nair KM. Zinc inhibits oxidative stress-induced iron signaling and apoptosis in Caco-2 cells. Free Radic Biol Med 2010; 48: 961-8.

Kim EY, Ham SK, Bradke D, Ma Q, Han O. Ascorbic Acid offsets the inhibitory effect of bioactive dietary polyphenolic compounds on transepithelial iron transport in caco-2 intestinal cells. J Nutr 2011; 141: 828-34.

Laparra JM, Barbera R, Alegria A, Glahn RP, Miller DD. Purified glycosaminoglycans from cooked haddock may enhance Fe uptake via endocytosis in a Caco-2 cell culture model. J Food Sci 2009; 74: H168-73.

Laparra JM, Glahn RP, Miller DD. Bioaccessibility of phenols in common beans ( Phaseolus vulgaris L.) and iron (Fe) availability to Caco-2 cells. J Agric Food Chem 2008; 56: 10999-1005.

Sorensen AD, Bukhave K. Iron uptake by Caco-2 cells following in vitro digestion: effects of heat treatments of pork meat and pH of the digests. J Trace Elem Med Biol 2010; 24: 230-5.

Glahn RP, Lee OA, Yeung A, Goldman MI, Miller DD. Caco-2 cell ferritin formation predicts nonradiolabeled food iron availability in an in vitro digestion/Caco-2 cell culture model. J Nutr 1998; 128: 1555-61.

Arredondo M, Salvat V, Pizarro F, Olivares M. Smaller iron particle size improves bioavailability of hydrogen-reduced iron-fortified bread. Nutr Res 2006; 26: 235-9.

Han O, Fleet JC, Wood RJ. Reciprocal regulation of HFE and NNamp2 gene expression by iron in human intestinal cells. J Nutr 1999; 129: 98-104.

Ferruzza S, Scarino ML, Rotilio G, et al. Copper treatment alters the permeability of tight junctions in cultured human intestinal Caco-2 cells. Am J Physiol 1999; 277: G1138-48.

Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388: 482-8.

Harvey RS, Reffitt DM, Doig LA, et al. Ferric trimaltol corrects iron deficiency anaemia in patients intolerant of iron. Aliment Pharmacol Ther 1998; 12: 845-8.

Barrand MA, Callingham BA. Evidence for regulatory control of iron uptake from ferric maltol across the small intestine of the rat. Br J Pharmacol 1991; 102: 408-14.

Singh RK, Barrand MA. Lipid peroxidation effects of a novel iron compound, ferric maltol. A comparison with ferrous sulphate. J Pharm Pharmacol 1990; 42: 276-9.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2012 Bianca I. Mergler, Ewgenia Roth, Sylvaine F.A. Bruggraber, Jonathan J. Powell, Dora I.A. Pereira